Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8070691 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| Cyclohexane SCHEMBL2492289 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL671850 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL21656667 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL5700121 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL670619 | 1.00 | EPHX1 (0.59) | EPHX1TP53KDM4EGMNNLMNA | |
| Hydrochloric Acid SCHEMBL8201526 | 0.97 | EPHX1 (0.56) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL4609721 | 0.97 | — | — | |
| SCHEMBL15531073 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL30866173 | 0.89 | KDM4E (0.46) | EPHX1TP53KDM4EGMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025040153-A1 | METHOD FOR PREPARING ISOCYANATE AND DEVICE | 摩珈(上海)生物科技有限公司 | 2025-02-27 | — | — | WO | claimed |
| US-20250051268-A1 | METHOD FOR PREPARING ISOCYANATE BY MEANS OF GAS-PHASE SOLVENT-FREE METHOD | MOJIA (SHANGHAI) BIOTECH CO., LTD. (CN) | 2025-02-13 | — | — | US | claimed |
| CN-118165227-A | Polyisocyanate composition with stable chromaticity after dilution and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| EP-3154937-B1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | FINA TECHNOLOGY (US) | 2024-05-22 | — | — | EP | claimed |
| WO-2024007204-A1 | METHOD FOR PREPARING ISOCYANATE BY COMBINING SUPERCRITICAL PHOSGENATION METHOD WITH PIPING METHOD | 摩珈(上海)生物科技有限公司 | 2024-01-11 | — | — | WO | claimed |
| CN-115043758-B | Method for preparing isocyanate by combining supercritical phosgenation method and pipelining method | 摩珈(上海)生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-115093348-B | Method for preparing isocyanate by pipeline phosgene method | 摩珈(上海)生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-115108942-B | Method for preparing isocyanate by supercritical phosgenation reaction | 摩珈(上海)生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-113105364-B | Method and system for producing isocyanates | 广安摩珈生物科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| WO-2023108620-A1 | METHOD FOR PREPARING ISOCYANATE BY MEANS OF GAS-PHASE SOLVENT-FREE METHOD | 摩珈(上海)生物科技有限公司 | 2023-06-22 | — | — | WO | claimed |
| CN-107337615-A | A kind of preparation method of isocyanates | 万华化学集团股份有限公司 | 2017-11-10 | — | — | CN | claimed |
| EP-3154937-A1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | Fina Technology, Inc. (US) | 2017-04-19 | — | — | EP | claimed |
| CN-106536094-A | Silver-coated copper nanowire and preparation method therefor | 柏业公司 | 2017-03-22 | — | — | CN | claimed |
| WO-2015191721-A1 | CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM | FINA TECHNOLOGY, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| EP-2486975-B1 | FAST MIXING REACTOR AND USE THEREOF | WANHUA CHEMICAL GROUP CO LTD (CN) | 2015-09-23 | — | — | EP | claimed |
| US-20120107616-A1 | Laminates Joined by Polyurethane Hot-Melt Adhesive and Process for Bonding Plasticizer-Containing Plastics | SIKA TECHNOLOGY AG (CH) | 2012-05-03 | — | — | US | claimed |
| WO-2010063741-A1 | ALDIMINE AND COMPOSITION CONTAINING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2010-06-10 | — | — | WO | claimed |
| US-20080280145-A1 | moisture-reactive hot-melt adhesive which comprises at least one aldimine and at least one polyurethane polymer ( polyesterurethane copolymer, polyetherurethane copolymer)which contains isocyanate groups and is solid at room temperature; bonded assembly is notable for improved adhesive | SIKA TECHNOLOGY AG (CH) | 2008-11-13 | — | — | US | claimed |
| US-20080138537-A1 | Low color polyimide compositions useful in optical type applications and methods and compositions relating thereto | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2008-06-12 | — | — | US | claimed |
| EP-1749850-A1 | Low color polyimide compositions useful in optical type applications and methods and compositions related thereto | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051268-A1 | METHOD FOR PREPARING ISOCYANATE BY MEANS OF GAS-PHASE SOLVENT-FREE METHOD | TST, GRHPR, IDH2 | EPHX1 2679/4885TP53 1461/4885KDM4E 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.